There are a couple of points. In the spirit of transparency, companies should be notified if you're going to go to that extraordinary step of overriding patents to create compulsory licence. I think out of due process you have a right to know. I don't see any reason why, if the generic has a country identified through the WTO, that a voluntary licence from our industry would not be issued.
On April 23rd, 2007. See this statement in context.